Bayer Aktiengesellschaft (WSE:BAY)

Poland flag Poland · Delayed Price · Currency is PLN
94.28
+2.74 (2.99%)
Apr 23, 2025, 5:51 PM CET
-20.44%
Market Cap 92.86B
Revenue (ttm) 199.42B
Net Income (ttm) -10.92B
Shares Out n/a
EPS (ttm) -11.13
PE Ratio n/a
Forward PE n/a
Dividend 0.48 (0.50%)
Ex-Dividend Date Apr 28, 2025
Volume 531
Average Volume 129
Open 94.72
Previous Close 91.54
Day's Range 94.28 - 94.72
52-Week Range 78.97 - 132.50
Beta n/a
RSI 55.70
Earnings Date May 13, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 90,587
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BAY
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.